Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract LB228: Replication stress activates the DNA damage response and contributes to lapatinib resistance in HER2-positive SK-BR-3 cells

So Hyeon Kim, Ahrum Min, Seongyeong Kim, Yu Jin Kim, Sujin Ham, Hae Min Hwang, Minyoung Lee, Changyun Lee, Jinyong Kim, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im

Cancer Res (2023) 83 (8_Supplement): LB228.

https://doi.org/10.1158/1538-7445.AM2023-LB228

Published: 14 April 2023

View article titled, Abstract LB228: Replication stress activates the DNA damage response and contributes to lapatinib resistance in HER2-positive SK-BR-3 cells

Journal Articles

Abstract 5978: Cyclin dependent kinase 9 inhibitor AZD4573 induces cell death through DNA damage accumulation in breast cancer cells in vitro

Minyoung Lee, So Hyeon Kim, Sujin Ham, Hae Min Hwang, Youlim Noh, Yu-Jin Kim, Ahrum Min, Jinyong Kim, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im

Cancer Res (2023) 83 (7_Supplement): 5978.

https://doi.org/10.1158/1538-7445.AM2023-5978

Published: 04 April 2023

View article titled, Abstract 5978: Cyclin dependent kinase 9 inhibitor AZD4573 induces cell death through DNA damage accumulation in breast cancer cells <em>in vitro</em>

Journal Articles

Abstract PS16-28: Runx3 regulates emt during development lapatinib resistance

So Hyeon Kim, Ahrum Min, Seongyeong Kim, Yoonjung Park, Yu Jin Kim, Seock-Ah Im

Cancer Res (2021) 81 (4_Supplement): PS16-28.

https://doi.org/10.1158/1538-7445.SABCS20-PS16-28

Published: 15 February 2021

View article titled, Abstract PS16-28: Runx3 regulates emt during development lapatinib resistance

Journal Articles

Abstract PS5-40: CDKN2A loss can be a predictive marker of palbociclib in breast and gastric cancer

Ahrum Min, Yu Jin Kim, Miso Lee, Kyung-Hun Lee, Seock-Ah Im

Cancer Res (2021) 81 (4_Supplement): PS5-40.

https://doi.org/10.1158/1538-7445.SABCS20-PS5-40

Published: 15 February 2021

View article titled, Abstract PS5-40: CDKN2A loss can be a predictive marker of palbociclib in breast and gastric cancer

Journal Articles

Abstract 3886: Impact of nanosuspension of CZ48, a lactone stabilized camptothecin, on the biliary excretion and enterohepatic recycling of its active moiety, camptothecin

Diana S-L Chow, Yu Jin Kim, Dong Dong, Xiaohui Li

Cancer Res (2019) 79 (13_Supplement): 3886.

https://doi.org/10.1158/1538-7445.AM2019-3886

Published: 01 July 2019

View article titled, Abstract 3886: Impact of nanosuspension of CZ48, a lactone stabilized camptothecin, on the biliary excretion and enterohepatic recycling of its active moiety, camptothecin

Journal Articles

Abstract 2814: Antitumor effects of WEE1 inhibitor, AZD1775 alone or in combination with PARP inhibitor in triple negative breast cancer cells

Dong Hyeon Ha, Arrum Min, Seongyeong Kim, So Hyeon Kim, Hyemin Jang, Yu Jin Kim, Daeun Jung, YoonJung Park, Koung Jin Suh, Kyung-Hun Lee, Tae-Yong Kiim Kim, Seock-Ah Im

Cancer Res (2018) 78 (13_Supplement): 2814.

https://doi.org/10.1158/1538-7445.AM2018-2814

Published: 01 July 2018

View article titled, Abstract 2814: Antitumor effects of WEE1 inhibitor, AZD1775 alone or in combination with PARP inhibitor in triple negative breast cancer cells

Journal Articles

Abstract 2318: Palbociclib, a CDK4/6 inhibitor, suppresses proliferation of triple negative breast cancer

Ahrum Min, Yu Jin Kim, Hyemin Hang, Jee Min Lim, Seongyeong Kim, So Hyeon Kim, Koung Jin Suh, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im

Cancer Res (2018) 78 (13_Supplement): 2318.

https://doi.org/10.1158/1538-7445.AM2018-2318

Published: 01 July 2018

View article titled, Abstract 2318: Palbociclib, a CDK4/6 inhibitor, suppresses proliferation of triple negative breast cancer

Journal Articles

Abstract 3433: Genomic analysis of patient-derived xenograft (PDX) model from metastatic breast cacner

Dongjin Shin, Seock-Ah Im, Seongyeong Kim, Minjung Kim, Yu Jin Kim, Jinjoo Kang, Ahrum Min, Jieun Lee, Giyong Jang, Deukchae Na, Kyung-Hun Lee, Jongil Kim

Cancer Res (2018) 78 (13_Supplement): 3433.

https://doi.org/10.1158/1538-7445.AM2018-3433

Published: 01 July 2018

View article titled, Abstract 3433: Genomic analysis of patient-derived xenograft (PDX) model from metastatic breast cacner

Journal Articles

Abstract 306: Antitumor effect of Wee1 inhibitor in gastric cancer cells

Seongyeong Kim, Ahrum Min, So Hyeon Kim, Dong Hyeon Ha, Hyemin Jang, Yu JIn Kim, Hee Jun Kim, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang, Seock-Ah Im

Cancer Res (2017) 77 (13_Supplement): 306.

https://doi.org/10.1158/1538-7445.AM2017-306

Published: 01 July 2017

View article titled, Abstract 306: Antitumor effect of Wee1 inhibitor in gastric cancer cells

Journal Articles

Abstract 4116: Acquired lapatinib resistant induces EMT-phenotype in breast cancer cells via Src and RUNX3

So Hyeon Kim, Ahrum Min, Seongyeong Kim, Dong Hyeon Ha, Hyemin Jang, Yu Jin Kim, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im

Cancer Res (2017) 77 (13_Supplement): 4116.

https://doi.org/10.1158/1538-7445.AM2017-4116

Published: 01 July 2017

View article titled, Abstract 4116: Acquired lapatinib resistant induces EMT-phenotype in breast cancer cells via Src and RUNX3

Journal Articles

Abstract LB-107: Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells via modulation of DNA damage response

Ahrum Min, Seock-Ah Im, Hyemin Jang, Seongyeong Kim, So Hyeon Kim, Yu Jin Kim, Debora Keunyoung Kim, Yaewon Yang, Koung Jin Suh, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang

Cancer Res (2016) 76 (14_Supplement): LB-107.

https://doi.org/10.1158/1538-7445.AM2016-LB-107

Published: 15 July 2016

View article titled, Abstract LB-107: Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells via modulation of DNA damage response

Journal Articles

Abstract 2785: LYN is a new prognostic and therapeutic target in non-small cell lung cancer

Yu Jin Kim, Minjung Sung, Min Jeong Park, Young Kee Shin, Yoon-La Choi

Cancer Res (2014) 74 (19_Supplement): 2785.

https://doi.org/10.1158/1538-7445.AM2014-2785

Published: 01 October 2014

View article titled, Abstract 2785: LYN is a new prognostic and therapeutic target in non-small cell lung cancer

Journal Articles

Abstract 4180: Clonal evolution of tumor cell population in a patient with repetitively recurrent dermatofibrosarcoma protuberance (DFSP)

Ensel Oh, Yoon-La Choi, Sang Yun Ha, Eun Hee Lee, Jeeyun Lee, Sung Joo Kim, Yu Jin Kim, Ji-Young Song, Young Kee Shin, Hae Min Jung, Mi Jeong Kwon

Cancer Res (2014) 74 (19_Supplement): 4180.

https://doi.org/10.1158/1538-7445.AM2014-4180

Published: 01 October 2014

View article titled, Abstract 4180: Clonal evolution of tumor cell population in a patient with repetitively recurrent dermatofibrosarcoma protuberance (DFSP)

Journal Articles

Abstract 4391: MET is a potential therapeutic target and a candidate for combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.

Yu Jin Kim, Jong-Sun Choi, Ji-Young Song, Kyungsoo Jung, Ensel Oh, Young Kee Shin, Yoon-La Choi

Cancer Res (2013) 73 (8_Supplement): 4391.

https://doi.org/10.1158/1538-7445.AM2013-4391

Published: 15 April 2013

View article titled, Abstract 4391: MET is a potential therapeutic target and a candidate for combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.

Journal Articles

Abstract 3591: Efficacy and distribution of intratumoral paclitaxel given alone or in combination with doxorubicin using hydrogel in nude mice

Joo-Ho Lee, Kwang-Suck Kim, Soo-Yeon Kim, Yu Jin Kim, Ahmed M. Al-abd, Ki-Yun Hong, Soo-Chang Song, Hyo-Jeong Kuh

Cancer Res (2010) 70 (8_Supplement): 3591.

https://doi.org/10.1158/1538-7445.AM10-3591

Published: 15 April 2010

View article titled, Abstract 3591: Efficacy and distribution of intratumoral paclitaxel given alone or in combination with doxorubicin using hydrogel in nude mice

Journal Articles

Functional Interaction between BubR1 and Securin in an Anaphase-Promoting Complex/Cyclosome^Cdc20–Independent Manner

Hyun-Soo Kim, Yoon-Kyung Jeon, Geun-Hyoung Ha, Hye-Young Park, Yu-Jin Kim, Hyun-Jin Shin, Chang Geun Lee, Doo-Hyun Chung, Chang-Woo Lee

Cancer Res (2009) 69 (1): 27–36.

https://doi.org/10.1158/0008-5472.CAN-08-0820

Published: 31 December 2008

View article titled, Functional Interaction between BubR1 and Securin in an Anaphase-Promoting Complex/Cyclosome<sup>Cdc20</sup>–Independent Manner

Includes: Supplementary data

Journal Articles

Diallyl trisulfide inhibits phorbol ester-induced COX-2 expression in human mammary epithelial cells: IKKβ as a prime molecular target

Hye-Kyung Na, Yu-Jin Kim, Eun-Hee Kim, Young-Joon Surh

Cancer Res (2008) 68 (9_Supplement): 4667.

Published: 01 May 2008

View article titled, Diallyl trisulfide inhibits phorbol ester-induced COX-2 expression in human mammary epithelial cells: IKKβ as a prime molecular target

NARROW

Abstract LB228: Replication stress activates the DNA damage response and contributes to lapatinib resistance in HER2-positive SK-BR-3 cells

Abstract 5978: Cyclin dependent kinase 9 inhibitor AZD4573 induces cell death through DNA damage accumulation in breast cancer cells in vitro

Abstract PS16-28: Runx3 regulates emt during development lapatinib resistance

Abstract PS5-40: CDKN2A loss can be a predictive marker of palbociclib in breast and gastric cancer

Abstract 3886: Impact of nanosuspension of CZ48, a lactone stabilized camptothecin, on the biliary excretion and enterohepatic recycling of its active moiety, camptothecin

Abstract 2814: Antitumor effects of WEE1 inhibitor, AZD1775 alone or in combination with PARP inhibitor in triple negative breast cancer cells

Abstract 2318: Palbociclib, a CDK4/6 inhibitor, suppresses proliferation of triple negative breast cancer

Abstract 3433: Genomic analysis of patient-derived xenograft (PDX) model from metastatic breast cacner

Abstract 306: Antitumor effect of Wee1 inhibitor in gastric cancer cells

Abstract 4116: Acquired lapatinib resistant induces EMT-phenotype in breast cancer cells via Src and RUNX3

Abstract LB-107: Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells via modulation of DNA damage response

Abstract 2785: LYN is a new prognostic and therapeutic target in non-small cell lung cancer

Abstract 4180: Clonal evolution of tumor cell population in a patient with repetitively recurrent dermatofibrosarcoma protuberance (DFSP)

Abstract 4391: MET is a potential therapeutic target and a candidate for combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.

Abstract 3591: Efficacy and distribution of intratumoral paclitaxel given alone or in combination with doxorubicin using hydrogel in nude mice

Functional Interaction between BubR1 and Securin in an Anaphase-Promoting Complex/Cyclosome^Cdc20–Independent Manner

Diallyl trisulfide inhibits phorbol ester-induced COX-2 expression in human mammary epithelial cells: IKKβ as a prime molecular target

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only